Redefining care: How ThrIVewell Infusion is putting patients first

Infusion therapy is a lifeline for people living with autoimmune disorders and chronic conditions. It’s also frequently ...

Minaris and Genetix Biotherapeutics Expand Manufacturing Partnership to Support Commercial Supply for LYFGENIA™ (lovotibeglogene autotemcel)

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...